| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | — | -71.7% |
| R&D Expense | $17.9M | — | -46.9% |
| SG&A Expense | $8.1M | — | -44.9% |
| Operating Income | -$24.9M | — | +44.2% |
| Pre-tax Income | -$22.9M | — | +43.4% |
| Income Tax | $0 | — | — |
| Net Income | -$22.9M | — | +43.3% |
| EPS (Basic) | -$0.21 | — | +48.8% |
| EPS (Diluted) | -$0.21 | — | +48.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.0M | +17.0% | +102.7% |
| Short-term Investments | $129.6M | -31.9% | -59.1% |
| Current Assets | $215.1M | -19.3% | -41.3% |
| Total Assets | $239.9M | -18.2% | -41.2% |
| Current Liabilities | $41.0M | -41.1% | -62.7% |
| Long-term Debt | $8.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$49.8M | — | +18.0% |
| Capital Expenditures | $118K | — | +490.0% |
| Investing Cash Flow | $60.9M | — | -7.3% |
| Financing Cash Flow | $25K | — | — |
| Free Cash Flow | -$49.9M | — | +17.9% |
| -12.4% |
| Total Liabilities | $229.5M | -12.6% | -26.8% |
| Stockholders' Equity | $10.4M | -66.1% | -89.0% |